FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots
The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thro...


















